EXECUTIVE EMPLOYMENT AGREEMENT BY AND BETWEEN HORIZON PHARMA USA, INC. AND DR. JEFFERY KENTAgreement by And • May 8th, 2019 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • Illinois
This Executive Employment Agreement (hereinafter referred to as the “Agreement”), is entered into by and between Horizon Pharma, Inc., a Delaware corporation, and its wholly owned subsidiary, Horizon Pharma USA, Inc., a Delaware corporation, each having a principal place of business at 150 S. Saunders Road, Lake Forest, IL 60045, (hereinafter referred to together as the “Company”) and Dr. Jeffery Kent (hereinafter referred as to the “Executive”).The terms of this Agreement shall be effective commencing May 1, 2019 (the “Effective Date”).
License Agreement by and among a Swiss corporation; Hoffmann-La Roche Inc. a New Jersey corporation and River Vision LLC, a Delaware limited liability companyLicense Agreement • May 8th, 2019 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations
RIVER VISION LLC, a limited liability company organized and existing under the laws of Delaware, with its principal office at One Rockefeller Plaza, New York NY, 10020, U.S.A. (“River Vision”).
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE HORIZON THERAPEUTICS PLC HAS DETERMINED THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO HORIZON THERAPEUTICS PLC...Supply Agreement • May 8th, 2019 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • New York
COMMERCIAL SUPPLY AGREEMENT (DRUG PRODUCT)Commercial Supply Agreement • May 8th, 2019 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations
THIS COMMERCIAL SUPPLY AGREEMENT (this “Agreement”) is entered into and effective this 18th day of November, 2018 (“Effective Date”) by and between Catalent Indiana, LLC (“Catalent”), an Indiana limited liability company with offices at 1300 South Patterson Drive, Bloomington, Indiana 47403, and Horizon Pharma Ireland Limited (“Client”), a company incorporated under the laws of Ireland with offices at Connaught House, 1 Burlington Road, Dublin 4, Ireland. In this Agreement, Catalent and Client each may be referred to individually as a “Party” and together as “Parties.”
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • May 8th, 2019 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • California
This Exclusive License Agreement (this “Agreement”) is entered into as of this 5th day of December, 2012 (the “Effective Date”), by and between River Vision Development Corp., a Delaware corporation with a principal place of business located at do Narrow River Management LP, One Rockefeller Plaza, New York, NY, 10020 (“Licensee”) and Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, a California corporation with a principal place of business located at 1124 West Carson Street, Torrance, CA, 90502 (“Licensor”) .
